CLARIVATE PLC (CLVT) — Insider Trading

AI-Powered SEC Filing Analysis

← All CLVT filings

Want the newest filings?

This analysis covers the filing from 2026-05-05. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Earlier Insider Trading filings

Filed: 2026-04-02
  • Insider Kenneth L. Cornick, a director of Clarivate PLC, acquired 11,363 ordinary shares of the company on March 31, 2026, demonstrating his confidence in the company.
  • Cornick also holds an indirect beneficial ownership of 1,100,000 ordinary shares through Cornick Family Investor, LLC, which he controls with his spouse.
  • The acquisition price of $2.53 per share suggests Cornick believes the stock is undervalued and has growth potential.
Filed: 2026-04-02
  • Jane L Okun Bomba, a director at Clarivate PLC, acquired 11,363 ordinary shares on March 31, 2026, at a price of $2.53 per share, indicating her continued confidence in the company.
  • Bomba also sold 621 shares to cover tax withholding, maintaining a total beneficial ownership of 240,264 shares plus 49,750 shares held indirectly through a trust.
  • The transaction was made as part of Bomba's director compensation, with the share award replacing a cash retainer of $28,750, aligning her interests with shareholders.
Filed: 2026-04-02
  • Insider Andrew Miles Snyder acquired 20,256 ordinary shares of Clarivate PLC (CLVT) on March 31, 2026, indicating his confidence in the company's prospects.
  • Snyder also holds significant indirect beneficial ownership in Clarivate through various entities, including Cambridge Information Group Inc. and related LLCs, suggesting he has a substantial stake in the company.
  • The transaction was made in lieu of cash retainer for Snyder's services as a board member, suggesting he prefers to receive equity compensation rather than cash.
Filed: 2026-03-17
  • Insider Mourad Maroun S., the President of IP, acquired a significant number of 377,358 ordinary shares in Clarivate PLC, indicating management's confidence in the company's future prospects.
  • Mourad Maroun S. also holds an indirect beneficial ownership of 105,000 ordinary shares through his spouse, suggesting a substantial personal investment in the company.
  • The transaction was executed at a price of $0 per share, potentially indicating the shares were acquired through an equity compensation plan or other non-market transaction.
Filed: 2026-03-17
  • Michael M. Easton, the Senior VP and CAO of Clarivate PLC, made a large direct purchase of 282,075 ordinary shares on March 15, 2026, potentially indicating his confidence in the company's prospects.
  • Easton also gifted 26,500 shares to a charitable organization on March 13, 2026, which could signal his philanthropic intentions.
  • The company withheld 30,456 shares from Easton's account on March 15, 2026 to cover tax obligations, suggesting a vesting of restricted share units.
Filed: 2026-03-17
  • Insider William E. Graff, the EVP and Chief Information Officer, acquired 254,716 ordinary shares of Clarivate PLC, indicating confidence in the company's future performance.
  • Graff also sold 23,838 shares to cover tax obligations, suggesting he continues to hold a sizable stake in the company.
  • The transaction represents a significant increase in Graff's direct ownership, potentially signaling his belief in the company's growth prospects.
Filed: 2026-03-17
  • Matitiahu S. Shem Tov, the Chief Executive Officer of Clarivate PLC, acquired 1,132,075 ordinary shares of the company on March 15, 2026 at no cost, indicating a significant increase in his ownership stake.
  • Shem Tov also disposed of 125,471 ordinary shares on the same date, likely to cover tax obligations related to the share acquisition, suggesting a continued commitment to the company.
  • The reporting person holds a total of 2,338,415 ordinary shares directly, along with an additional 320,603 shares held indirectly through the IBI Trust Management, indicating a substantial insider ownership position.
Filed: 2026-03-17
  • Insider Veinstein Bar, the President of Analytics & Growth, acquired 377,358 ordinary shares of Clarivate PLC, suggesting confidence in the company's future prospects.
  • The share acquisition represents a significant 30% increase in Veinstein's direct beneficial ownership, indicating a positive outlook on the company's performance.
  • Insider trading activity, such as this open-market purchase, can provide insight into management's confidence in the company's long-term growth and strategy.
Filed: 2026-03-17
  • The reporting person, Jonathan Mark Collins, acquired 471,698 ordinary shares in Clarivate PLC on March 15, 2026, indicating an increase in his ownership stake in the company.
  • Collins also disposed of 43,987 shares to cover tax withholding obligations and transferred 35,741 shares to his former spouse as part of a divorce settlement.
  • The insider transactions suggest Collins is aligning his personal holdings with the company's long-term performance, despite the partial reduction in his direct ownership.
Filed: 2026-03-17
  • Henry Levy, the President of Life Sciences & Health at Clarivate PLC, has acquired 377,358 ordinary shares in the company through a stock award, indicating potential confidence in the company's future performance.
  • Levy also disposed of 35,402 shares to cover tax obligations, suggesting he is retaining a substantial portion of his equity stake in the company.
  • The timing of this transaction, which occurred in March 2026, may provide insight into the company's recent performance and future growth prospects.
Filed: 2026-02-20
  • The reporting person, Jonathan Mark Collins, acquired 35,573 ordinary shares of Clarivate PLC through the vesting of performance share units granted in 2023.
  • The reporting person also sold 17,396 shares to cover tax liability incident to the vesting, indicating a partial liquidation of his equity position.
  • The reporting person continues to hold 795,224 ordinary shares, representing his ongoing commitment and alignment with Clarivate's long-term success.
Filed: 2026-02-20
  • Insider Henry Levy, President of Life Sciences & Health, acquired 36,847 ordinary shares of Clarivate PLC, indicating his confidence in the company's prospects.
  • Levy also disposed of 18,115 shares to cover tax liabilities associated with the vesting of performance share units, suggesting he is holding a significant portion of his ownership.
  • The transaction suggests Levy's alignment with Clarivate's long-term growth strategy, as the performance share units were granted in 2023 and vested upon the achievement of certain performance conditions.
Filed: 2026-02-20
  • Michael M. Easton, the Senior VP and CAO of Clarivate PLC, acquired 7,114 ordinary shares and disposed of 3,521 shares through a tax withholding transaction on February 18, 2026.
  • The transaction was related to the vesting of Easton's performance share units granted in 2023, indicating his long-term incentive alignment with the company.
  • Easton's total beneficial ownership of Clarivate shares following the reported transaction is 497,764, suggesting he maintains a significant stake in the company.
Filed: 2026-02-20
  • Insider Bar Veinstein, the President of Analytics and Governance, acquired 36,847 ordinary shares of Clarivate PLC (CLVT), indicating management's confidence in the company's prospects.
  • The shares were acquired through the settlement of performance share units granted in 2023, suggesting the company met its performance targets.
  • Veinstein's increased stake in the company, now totaling 885,658 shares, aligns his interests with those of shareholders and signals his long-term commitment to Clarivate PLC.

Other reports for CLARIVATE PLC

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.